A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension

Novartis

Status and phase: Completed; Phase 3

Conditions: Hypertension

Treatments: Drug: VALSARTAN, VALSARTAN+HYDROCHLOROTHIAZIDE

Study type: Interventional

Funder types: Industry

Identifiers

NCT00241007

CVAH631C2301E1

Details and patient eligibility

About

SAFETY EXTENSION STUDY TO THE CORE STUDY CVAH631C2301

Enrollment: 836 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

SUCCESSFUL COMPLETION OF STUDY CVAH631C2301

Exclusion criteria

• NONE

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind